[2010年至2023年间匈牙利公开资助体外受精程序的利用率]
Dalma Pónusz-Kovács1,2,3, Tímea Molnárné Csákvári1,2,3, Róbert Pónusz1,2,3
11 Pécsi Tudományegyetem, Egészségtudományi Kar, Egészségbiztosítási Intézet Pécs, Vörösmarty u. 3., 7621 Magyarország.
Orvosi hetilap
|July 20, 2025
概括
在匈牙利,增加国家资金推动了体外受精 (IVF) 治疗,到2023年患者人数将近三倍. 然而,尽管生育治疗的总体增加,但试管婴儿接入的区域差异仍然很大.
科学领域:
- 生殖医学和内分泌学.
- 公共卫生政策和医疗保健管理
背景情况:
- 在全球范围内,不孕症影响了1.86亿人,其中12-17%的生育年龄夫妇遇到了困难.
- 辅助生殖技术,特别是体外受精 (IVF),由于不孕率的上升,需求量很高.
研究的目的:
- 分析匈牙利公共资助的医疗保健系统中体外受精 (IVF) 服务的利用情况.
- 评估从2010年到2023年与试管婴儿治疗相关的趋势,区域不平等和人口因素.
主要方法:
- 以国家医疗保险基金管理局和国家医院总局的数据为依据的回顾性定量研究.
- 评估与试管婴儿相关的住院病例,包括医院贡献,领土分布和与诊断相关的群体.
- 使用了描述性统计和线性回归分析.
主要成果:
- 在2010年至2023年期间,共记录了127,616例试管婴儿住院病例.
- 从2019年开始,IVF病例的显著增加被观察到,与2010年相比,2023年患者数量将近2.5倍.
- 报告指出,在使用服务方面存在持续显著的领土差异,患者平均年龄 (2010-2020年) 的上升趋势.
结论:
- 从2019年开始,国家更多地参与了对试管婴儿的资助,这对患者数量产生了积极的影响.
- 虽然试管婴儿的病例数量每年都在持续增加,但在获得试管婴儿方面仍然存在严重的区域不平等.
- 这些发现强调了需要制定战略,以解决试管婴儿供给中持续存在的领土差异.
相关概念视频
In Vitro Fertilization
400
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
400
Infertility in Females
405
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
405
Meiosis II
184.4K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
184.4K


